Use Of Molindone For The Treatment Of Impulsive Aggression In Children And Adolescents With Adhd
Posted Date: Jun 7, 2019
- Investigator: Caleb Adler
- Specialties: ADD/ADHD, Adolescent Psychiatry/Psychology, Psychiatry/Psychology
- Type of Study: Drug
This is an open label trial to evaluate the long term safety (up to 60 months) of a medication called Molindone in the treatment of Impulsive aggression in pediatric and adolescent subjects with ADHD when taken along with a standard ADHD medication.
Criteria:
The Subject Would Require To Be Diagnosed Historically With Adhd And Be On A Stable Dose Of A Fda Approved Adhd Medication Prior To Participating In The Study. Subjects With A History Of Mdd Or Any Psychotic Disorders Will Be Excluded. Subjects Are Enroll
Keywords:
Adhd, Add, Aggression
For More Information:
Dinesh Ganapathy
513-558-4413
ganapadh@ucmail.uc.edu